Abstract
Diversity has historically played a critical role in design of combinatorial libraries, screening sets and corporate collections for lead discovery. Large library design dominated the field in the 1990s with methods ranging anywhere from purely arbitrary through property based reagent selection to product based approaches. In recent years, however, there has been a downward trend in library size. This was due to increased information about the desirable targets gleaned from the genomics revolution and to the ever growing availability of target protein structures from crystallography and homology modeling. Creation of libraries directed toward families of receptors such as GPCRs, kinases, nuclear hormone receptors, proteases, etc., replaced the generation of libraries based primarily on diversity while single target focused library design has remained an important objective. Concurrently, computing grids and cpu clusters have facilitated the development of structure based tools that screen hundreds of thousands of molecules. Smaller “smarter” combinatorial and focused parallel libraries replaced those early un-focused large libraries in the twenty-first century drug design paradigm. While diversity still plays a role in lead discovery, the focus of current library design methods has shifted to receptor based methods, scaffold hopping/bio-isostere searching, and a much needed emphasis on synthetic feasibility. Methods such as “privileged substructures based design” and pharmacophore based design still are important methods for parallel and small combinatorial library design. This chapter discusses some of the possible design methods and presents examples where they are available.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Burbaum, J. J., Ohlmeyer, M. H. J., Reader, J. C., Henderson, I., Dillard, L. W., Li, G., Randle, T. L., Sigal, N. H., Chelsky, D., and Baldwin, J. J. (1995) A paradigm for drug discovery employing encoded combinatorial libraries Proc. Natl. Acad. Sci. U.S.A. 92(13), 6027–6031
Blondelle, S. E., Crooks, E., Ostresh, J. M., and Houghten, R. A. (1999) Mixture-based heterocyclic combinatorial positional scanning libraries: Discovery of bicyclic guanidines having potent antifungal activities against Candida albicans and Cryptococcus neoformans Antimicrob. Agents Chemother. 43(1), 106–114
Boger, D. L., Jiang, W., and Goldberg, J. (1999) Convergent solution-phase combinatorial synthesis with multiplication of diversity through rigid biaryl and diarylacetylene couplings J. Org. Chem. 64(19), 7094–7100
Ferry, G., Boutin, J. A., Atassi, G., Fauchere, J. L., and Tucker, G. C. (1997) Selection of a histidine-containing inhibitor of gelatinases through deconvolution of combinatorial tetrapeptide libraries Mol. Divers. 2(3), 135–146
Lutzke, R. A. P., Eppens, N. A., Weber, P. A., Houghten, R. A., and Plasterk, R. H. A. (1995) Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library Proc. Natl. Acad. Sci. U.S.A. 92(25), 11456–11460
Samson, I., Kerremans, L., Rozenski, J., Samyn, B., Van Beeumen, J., Van Aerschot, A., and Herdewijn, P. (1995) Identification of a peptide inhibitor against glycosomal phosphoglycerate kinase of Trypanosoma brucei by a synthetic peptide library approach Bioorg. Med. Chem. 3(3), 257–265
Bures, M. G., and Martin, Y. C. (1998) Computational methods in molecular diversity and combinatorial chemistry Curr. Opin. Chem. Biol. 2(3), 376–380
Van Drie, J. H., and Lajiness, M. S. (1998) Approaches to virtual library design Drug Discov. Today 3(6), 274–283
Spellmeyer, D. C., and Grootenhuis, P. D. J. (1999) Recent developments in molecular diversity. Computational approaches to combinatorial chemistry Annu. Rep. Med. Chem. 34, 287–296
Drewry, D. H., and Stanley Young, S. (1999) Approaches to the design of combinatorial libraries Chemom. Intell. Lab. Syst. 48(1), 1–20
Leach, A. R., and Hann, M. M. (2000) The in silico world of virtual libraries Drug Discov. Today 5(8), 326–336
Lewis, R. A., Pickett, S. D., and Clark, D. E. (2000) Computer-aided molecular diversity analysis and combinatorial library design Rev. Comput. Chem. 16, 1–51
Agrafiotis, D. K., Myslik, J. C., and Salemme, F. R. (1999) Advances in diversity profiling and combinatorial series design Annu. Rep. Comb. Chem. Mol. Divers. 2, 71–92
Willett, P. (2000) Chemoinformatics – Similarity and diversity in chemical libraries Curr. Opin. Biotechnol. 11(1), 85–88
Engels, M. F. M., and Venkatarangan, P. (2001) Smart screening: Approaches to efficient HTS Curr. Opin. Drug Discov. Devel. 4(3), 275–283
Andersson, P. M., Sjostrom, M., Wold, S., and Lundstedt, T. (2001) Strategies for subset selection of parts of an in-house chemical library J. Chemom. 15(4), 353–369
Andersson, P. M., Linusson, A., Wold, S., Sjostrom, M., Lundstedt, T., and Norden, B. (1999) Design of small libraries for lead exploration Mol. Divers. Drug Des. 197–220
Linusson, A., Gottfries, J., Lindgren, F., and Wold, S. (2000) Statistical molecular design of building blocks for combinatorial chemistry J. Med. Chem. 43(7), 1320–1328
Brannigan, L. H., Grieshaber, M. V., and Schnur, D. M. (1995) Experimental design in organic synthesis ACS Symp. Ser. 589(Computer-Aided Molecular Design), 225–235
Schnur, D. (1999) Design and diversity analysis of large combinatorial libraries using cell-based methods J. Chem. Inf. Comput. Sci. 39(1), 36–45
Schnur, D. M., and Venkatrangan, P. (2001) Applications of cell-based diversity to combinatorial library design. In: Ghose, A. K. (ed). Combinatorial Design and Evaluation, Marcel Dekker, New York, NY
Olsson, T., and Oprea, T. I. (2001) Cheminformatics: A tool for decision-makers in drug discovery Curr. Opin. Drug Discov. Devel. 4(3), 308–313
Xue, L., Stahura, F. L., and Bajorath, J. (2004) Cell-based partitioning Methods Mol. Biol. 275, 279–289
Pearlman Robert, S. DiverseSolutions Manual, Laboratory for Molecular Graphics and Theoretical Modeling, College of Pharmacy, University of Texas at Austin, Austin TX 78712
Cavallaro, C. L., Schnur, D.M., Johnson, S., and Tebben, A. Manuscript in preparation
van de Waterbeemd, H., Smith, D. A., Beaumont, K., and Walker, D. K. (2001) Property-based design: Optimization of drug absorption and pharmacokinetics J. Med. Chem. 44(9), 1313–1333
Palm, K., Stenberg, P., Luthman, K., and Artursson, P. (1997) Polar molecular surface properties predict the intestinal absorption of drugs in humans Pharm. Res. 14(5), 568–571
Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23(1–3), 3–25
Oprea, T. I. (2002) Current trends in lead discovery: Are we looking for the appropriate properties? J. Comput. Aided Mol. Des. 16(5/6), 325–334
Oprea, T. I., Zamora, I., and Ungell, A. -L. (2002) Pharmacokinetically based mapping device for chemical space navigation J. Comb. Chem. 4(4), 258–266
Oprea, T. I., and Gottfries, J. (2000) Toward minimalistic modeling of oral drug absorption1 J. Mol. Graph. Model. 17(5/6), 261–274
Evans, B. E., Rittle, K. E., Bock, M. G., DiPardo, R. M., Freidinger, R. M., Whitter, W. L., Lundell, G. F., Veber, D. F., Anderson, P. S., et al. (1988) Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists. J. Med. Chem. 31(12), 2235–2246
Patchett, A. A., and Nargund, R. P. (2000) Chapter 26. Privileged structures – An update Annu. Rep. Med. Chem. 35, 289–298
Mason, J. S., Morize, I., Menard, P. R., Cheney, D. L., Hulme, C., and Labaudiniere, R. F. (1999) New 4-point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures J. Med. Chem. 42(17), 3251–3264
Lamb, M. L., Bradley, E. K., Beaton, G., Bondy, S. S., Castellino, A. J., Gibbons, P. A., Suto, M. J., and Grootenhuis, P. D. J. (2004) Design of a gene family screening library targeting G-protein coupled receptors J. Mol. Graph. Model. 23(1), 15–21
Savchuk, N. P., Tkachenko, S. E., and Balakin, K. V. (2005) Rational design of GPCR-specific combinatorial libraries based on the concept of privileged substructures Methods Princ. Med. Chem. 23(Chemoinformatics in Drug Discovery), 287–313
Lowrie, J. F., Delisle, R. K., Hobbs, D. W., and Diller, D. J. (2004) The different strategies for designing GPCR and kinase targeted libraries Comb. Chem. High Throughput Screen. 7(5), 495–510
Prien, O. (2005) Target-family-oriented focused libraries for kinases-conceptual design aspects and commercial availability Chembiochem 6(3), 500–505
Stewart, E. L., Brown, P. J., Bentley, J. A., and Willson, T. M. (2001) Selection, application, and validation of a set of molecular descriptors for nuclear receptor ligands Abstracts of Papers, 222nd ACS National Meeting, Chicago, IL, United States, August 26–30, 2001, COMP-182
Lang, S. A., Kozyukov, A. V., Balakin, K. V., Skorenko, A. V., Ivashchenko, A. A., and Savchuk, N. P. (2003) Classification scheme for the design of serine protease targeted compound libraries J. Comput. Aided Mol. Des. 16(11), 803–807
Schuffenhauer, A., Zimmermann, J., Stoop, R., Van der Vyver, J. -J., Lecchini, S., and Jacoby, E. (2002) An ontology for pharmaceutical ligands and its application for in silico screening and library design J. Chem. Inf. Comput. Sci. 42(4), 947–955
Aureus Pharmaceuticals, 174, Quai de Jemmapes, 75010 Paris, France
Jubilant Biosys, Ltd.,8575 Window Latch Way, Columbia, MD 21045
Sertanty Inc., 1735 N. First St. #102, San Jose CA, 95112
McGregor, M. J., and Muskal, S. M. (2000) Pharmacophore fingerprinting. 2. Application to primary library design J. Chem. Inf. Comput. Sci. 40(1), 117–125
Naumann, T., and Matter, H. (2002) Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: Target family landscapes J. Med. Chem. 45(12), 2366–2378
Rad, R., Mracec, M., Mracec, M., and Oprea, T. (2007) The privileged structures hypothesis for G protein-coupled receptors – Some preliminary results Rev. Roum. Chim. 52(8–9), 853–858
Klabunde, T., and Hessler, G. (2002) Drug design strategies for targeting G-protein-coupled receptors Chembiochem 3(10), 928–944
Gooding, O. W. (2004) Process optimization using combinatorial design principles: Parallel synthesis and design of experiment methods Curr. Opin. Chem. Biol. 8(3), 297–304
Debnath, A. K. (2001) Quantitative structure–activity relationship (QSAR), a versatile tool in drug design. In: Ghose, A. K. (ed). Combinatorial Library Design and Evaluation, Marcel Dekker, Inc, New York, New York
Oprea, T. I., Davis, A. M., Teague, S. J., and Leeson, P. D. (2001) Is there a difference between leads and drugs? A historical perspective J. Chem. Inf. Comput. Sci. 41(5), 1308–1315
Teague, S. J., Davis, A. M., Leeson, P. D., and Oprea, T. (1999) The design of leadlike combinatorial libraries Angew. Chem. Int. Ed. 38(24), 3743–3748
Hansch, C., and Albert, L. (1995) Calculation of octanol-water partition coefficients by fragments. In: Heller, S. (ed). Exploring QSAR: Fundamentals and Applications in Chemistry and Biology, American Chemical Society, Washington, DC
Hansch, C., Hoekman, D., and Gao, H. (1996) Comparative QSAR: Toward a deeper understanding of chemicobiological interactions Chem. Rev. 96(3), 1045–1075
Oprea, T. I., Olah, M., Mracec, M., Rad, R., Ostopovici, L., Bora, A., Hadaruga, N., and Bologa, C. G. (2005) Mapping bioactivity space for fragment-based lead discovery Abstracts of Papers, 229th ACS National Meeting, San Diego, CA, United States, March 13–17, 2005, MEDI-277
Oprea, T. I. (2007) Lead-like, drug-like or “pub-like”: How different are they? Abstracts of Papers, 233rd ACS National Meeting, Chicago, IL, United States, March 25–29, 2007, CINF-014
Oprea, T. I. (2005) Pursuing leadlikeness in pharmaceutical research Jt. Meet. Med. Chem., Proc., Vienna, Austria, June 20–23, 2005, 1–4
Jaakola, V. -P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., Ijzerman, A. P., and Stevens, R. C. (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist Science 322(5905), 1211–1217
Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauss, N., Choe, H. -W., Hofmann, K. P., and Ernst, O. P. (2008) Crystal structure of opsin in its G-protein-interacting conformation Nature 455(7212), 497–502
Warne, T., Serrano-Vega, M. J., Baker, J. G., Moukhametzianov, R., Edwards, P. C., Henderson, R., Leslie, A. G. W., Tate, C. G., and Schertler, G. F. X. (2008) Structure of a b1-adrenergic G-protein-coupled receptor Nature 454(7203), 486–491
Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H. -W., and Ernst, O. P. (2008) Crystal structure of the ligand-free G-protein-coupled receptor opsin Nature 454(7201), 183–187
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H. -J., Kuhn, P., Weis, W. I., Kobilka, B. K., Stevens, R. C., Takeda, S., Kadowaki, S., Haga, T., Takaesu, H., Mitaku, S., Fredriksson, R., Lagerstrom, M. C., Lundin, L. G., Schioth, H. B., Pierce, K. L., Premont, R. T., Lefkowitz, R. J., Lefkowitz, R. J., Shenoy, S. K., and Rosenbaum, D. M. (2007) High-resolution crystal structure of an engineered human b2-adrenergic G protein-coupled receptor Science 318(5854), 1258–1265
Rasmussen, S. G. F., Choi, H. -J., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S., Edwards, P. C., Burghammer, M., Ratnala, V. R. P., Sanishvili, R., Fischetti, R. F., Schertler, G. F. X., Weis, W. I., and Kobilka, B. K. (2007) Crystal structure of the human b2 adrenergic G-protein-coupled receptor Nature 450(7168), 383–387
Worth, C. L., Kleinau, G., and Krause, G. (2009) Comparative sequence and structural analyses of G-protein-coupled receptor crystal structures and implications for molecular models PLoS One 4(9)
Mobarec, J. C., Sanchez, R., and Filizola, M. (2009) Modern homology modeling of g-protein coupled receptors: Which structural template to use? J. Med. Chem. 52(16), 5207–5216
Panigrahi, S. K., and Desiraju, G. R. (2003) Homology modelling in protein structure prediction: Epidermal growth factor receptor kinase domain Natl. Acad. Sci. Lett. 27(1 & 2), 1–11
Mahadevan, D., Bearss David, J., and Vankayalapati, H. (2003) Structure-based design of novel anti-cancer agents targeting aurora kinases Curr. Med. Chem. Anticancer Agents 3(1), 25–34
Mozzicafreddo, M., Cuccioloni, M., Cecarini, V., Eleuteri, A. M., and Angeletti, M. (2009) Homology modeling and docking analysis of the interaction between polyphenols and mammalian 20S proteasomes J. Chem. Inf. Model. 49(2), 401–409
Zhou, H., Singh, N. J., and Kim, K. S. (2006) Homology modeling and molecular dynamics study of West Nile virus NS3 protease: A molecular basis for the catalytic activity increased by the NS2B cofactor Proteins 65(3), 692–701
Majer, F., Pavlickova, L., Majer, P., Hradilek, M., Dolejsi, E., Hruskova-Heidingsfeldova, O., and Pichova, I. (2006) Structure-based specificity mapping of secreted aspartic proteases of Candida parapsilosis, Candida albicans, and Candida tropicalis using peptidomimetic inhibitors and homology modeling Biol. Chem. 387(9), 1247–1254
ClogP is available from Daylight Information Systems, Inc., 27401 Los Altos, Suite 360, Mission Viejo, CA, 92691
Carhart, R. E., Smith, D. H., and Venkataraghavan, R. (1985) Atom pairs as molecular features in structure–activity studies: Definition and applications J. Chem. Inf. Comput. Sci. 25(2), 64–73
Daylight Information Systems, Inc., 27401 Los Altos, Suite 360, Mission Viejo, CA, 92691
McGregor, M. J., and Muskal, S. M. (1999) Pharmacophore fingerprinting. 1. Application to QSAR and focused library design J. Chem. Inf. Comput. Sci. 39(3), 569–574
Beno, B. R., and Mason, J. S. (2001) The design of combinatorial libraries using properties and 3D pharmacophore fingerprints Drug Discov. Today 6(5), 251–258
Pearlman, R. S., and Smith, K. M. (1998) Software for chemical diversity in the context of accelerated drug discovery Drugs Future 23(8), 885–895
Pearlman, R. S., and Smith, K. M. (1999) Metric validation and the receptor-relevant subspace concept J. Chem. Inf. Comput. Sci. 39(1), 28–35
Kubinyi, H. (2004) 2D QSAR models: Hansch and Free-Wilson analyses Comput. Med. Chem. Drug Discovery, 539–570
Topliss, J. G. (1993) Some observations on classical QSAR Perspect. Drug Discovery Des. 1(2), 253–268
Martin, E. J., Blaney, J. M., Siani, M. A., Spellmeyer, D. C., Wong, A. K., and Moos, W. H. (1995) Measuring diversity: Experimental design of combinatorial libraries for drug discovery J. Med. Chem. 38(9), 1431–1436
Austel, V. (1995) Experimental design in synthesis planning and structure–property correlations. Experimental design Methods Princ. Med. Chem. 2, 49–62
Brannigan, L. H., Grieshaber, M. V., and Schnur, D. M. (1995) Use experimental design in organic synthesis Chem. Tech. 25(3), 29–35
Rose, S., and Stevens, A. (2003) Computational design strategies for combinatorial libraries Curr. Opin. Chem. Biol. 7(3), 331–339
Mitchell, T., and Showell, G. A. (2001) Design strategies for building drug-like chemical libraries Curr. Opin. Drug Discov. Devel. 4(3), 314–318
Gillet, V. J. (2002) Reactant- and product-based approaches to the design of combinatorial libraries J. Comput. Aided Mol. Des. 16(5/6), 371–380
Pearlman Robert, S. DiverseSolutions. Is available from Tripos, 1699 South Hanley Road, St. Louis, MO, 63144, http://www.tripos.com
GLIDE and CombiGLIDE are modules of the MAESTRO software package available from Schrödinger LLC, 120 West 45th Street, 17th Floor, New York, NY 10036. http://www.schrodinger.com
Pearlman Robert, S. Benchware (LibraryMaker/LibraryDesigner) was available from Tripos, 1699 South Hanley Road, St. Louis, MO, 63144, http://www.tripos.com
Matter, H. (1997) Selecting optimally diverse compounds from structure databases: A validation study of two-dimensional and three-dimensional molecular descriptors J. Med. Chem. 40(8), 1219–1229
Zuccotto, F. (2003) Pharmacophore features distributions in different classes of compounds J. Chem. Inf. Comput. Sci. 43(5), 1542–1552
Hall, L. H., and Kier, L. B. (1990) Determination of topological equivalence in molecular graphs from the topological state Quant. Struct.-Act. Relat. 9(2), 115–131
Hall, L. H., Mohney, B., and Kier, L. B. (1991) The electrotopological state: An atom index for QSAR Quant. Struct.-Act. Relat. 10(1), 43–51
Hassan, M., Bielawski, J. P., Hempel, J. C., and Waldman, M. (1996) Optimization and visualization of molecular diversity of combinatorial libraries Mol. Divers. 2(1/2), 64–74
Cerius2 was available from Accelrys, Inc., 9685 Scranton Road, San Diego, CA 92121-3752, but has since been incorporated into Discovery Studio. http://accelrys.com
Jamois, E. A., Lin, C. T., and Waldman, M. (2003) Design of focused and restrained subsets from extremely large virtual libraries J. Mol. Graph. Model. 22(2), 141–149
Brown, R. D., Hassan, M., and Waldman, M. (2004) Tools for designing diverse, druglike, cost-effective combinatorial libraries. In: Bajorath, J. (ed). Chemoinformatic: Concepts, Methods and Tools for Drug Discovery, first Ed., Humana Press, Totowa, NJ
Linusson, A., Gottfries, J., Olsson, T., Oernskov, E., Folestad, S., Norden, B., and Wold, S. (2001) Statistical molecular design, parallel synthesis, and biological evaluation of a library of thrombin inhibitors J. Med. Chem. 44(21), 3424–3439
MODDE is available form Umetrics, Inc., Kinnelon, N. J., Kinnelon, N. J. http://www.umetrics.com/
Lee, A., and Breitenbucher, J. G. (2003) The impact of combinatorial chemistry on drug discovery Curr. Opin. Drug Discov. Devel. 6(4), 494–508
Skiles, J. W., Gonnella, N. C., and Jeng, A. Y. (2001) The design, structure, and therapeutic application of matrix metalloproteinase inhibitors Curr. Med. Chem. 8(4), 425–474
Pauls, H. W., and Ewing, W. R. (2001) The design of competitive, small-molecule inhibitors of coagulation factor Xa. Curr. Top. Med. Chem. 1(2), 83–100
Pearlman, R. S., and Smith, K. M. (1998) Novel metrics and validation of metrics for chemical diversity Alfred Benzon Symp. 42(Rational Molecular Design in Drug Research), 165–185
Pearlman, R. S., and Smith, K. M. (1999) Novel algorithms for the design of diverse and focussed combinatorial libraries Book of Abstracts, 217th ACS National Meeting, Anaheim, Calif., March 21–25, COMP-197
Wang, X. -C., and Saunders, J. (2001) GPCR library design Abstracts of Papers, 222nd ACS National Meeting, Chicago, IL, United States, August 26–30, 200, MEDI-012
Mason, J. S., and Beno, B. R. (2000) Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: Simultaneous optimization and structure-based diversity J. Mol. Graph. Model. 18(4/5), 438–451
Pirard, B., and Pickett, S. D. (2000) Classification of kinase inhibitors using BCUT descriptors J. Chem. Inf. Comput. Sci. 40(6), 1431–1440
Manallack, D. T., Pitt, W. R., Gancia, E., Montana, J. G., Livingstone, D. J., Ford, M. G., and Whitley, D. C. (2002) Selecting screening candidates for kinase and G protein-coupled receptor targets using neural networks J. Chem. Inf. Comput. Sci. 42(5), 1256–1262
Mason, J. S., Good, A. C., and Martin, E. J. (2001) 3-D pharmacophores in drug discovery Curr. Pharm. Des. 7(7), 567–597
Good, A. C., Cho, S. -J., and Mason, J. S. (2004) Descriptors you can count on? Normalized and filtered pharmacophore descriptors for virtual screening J. Comput. Aided Mol. Des. 18(7–9), 523–527
Bradley, E. K., Beroza, P., Penzotti, J. E., Grootenhuis, P. D. J., Spellmeyer, D. C., and Miller, J. L. (2000) A rapid computational method for lead evolution: Description and application to a1-adrenergic antagonists J. Med. Chem. 43(14), 2770–2774
Lanctot, J. K., Putta, S., Lemmen, C., and Greene, J. (2003) Using ensembles to classify compounds for drug discovery J. Chem. Inf. Comput. Sci. 43(6), 2163–2169
Willett, P., Barnard, J. M., and Downs, G. M. (1998) Chemical similarity searching J. Chem. Inf. Comput. Sci. 38(6), 983–996
Lanctot, J. K., Srinivasan, J., Lamb, M. L., Lemmen, C., Eksterowicz, J. E., and Putta, S. (2003) Mitigating the sensitivity of pharmacophoric fingerprints Abstracts of Papers, 225th ACS National Meeting, New Orleans, LA, United States, March 23–27, 2003, COMP-323
Pickett, S. D., McLay, I. M., and Clark, D. E. (2000) Enhancing the hit-to-lead properties of lead optimization libraries J. Chem. Inf. Comput. Sci. 40(2), 263–272
Zuckermann, R. N., Martin, E. J., Spellmeyer, D. C., Stauber, G. B., Shoemaker, K. R., Kerr, J. M., Figliozzi, G. M., Goff, D. A., Siani, M. A., Simon, R., Banville, S. C., Brown, E. G., Wang, L., Richter, L. S., and Moos, W. H. (1994) Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library J. Med. Chem. 37(17), 2678–2685
Bradley, E. K., Miller, J. L., Saiah, E., and Grootenhuis, P. D. J. (2003) Informative library design as an efficient strategy to identify and optimize leads: Application to cyclin-dependent kinase 2 antagonists J. Med. Chem. 46(20), 4360–4364
Deanda, F., Stewart, E. L., Reno, M. J., and Drewry, D. H. (2008) Kinase-targeted library design through the application of the Pharmprint methodology J. Chem. Inf. Model. 48(12), 2395–2403
Deanda, F., and Stewart, E. L. (2004) Application of the PharmPrint methodology to two protein kinases J. Chem. Inf. Comput. Sci. 44(5), 1803–1809
Mason, J. S., and Cheney, D. L. (1999) Ligand-receptor 3-D similarity studies using multiple 4-point pharmacophores Pac. Symp. Biocomput. ‘99, Mauna Lani, Hawaii, Jan. 4–9, 1999, 456–467
Murray, C. M., and Cato, S. J. (1999) Design of libraries to explore receptor sites J. Chem. Inf. Comput. Sci. 39(1), 46–50
Arnold, J. R., Burdick, K. W., Pegg, S. C. H., Toba, S., Lamb, M. L., and Kuntz, I. D. (2004) SitePrint: Three-dimensional pharmacophore descriptors derived from protein binding sites for family based active site analysis, classification, and drug design J. Chem. Inf. Comput. Sci. 44(6), 2190–2198
Baroni, M., Cruciani, G., Sciabola, S., Perruccio, F., and Mason, J. S. (2007) A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application J. Chem. Inf. Model. 47(2), 279–294
Lamb, M. L., Bradley, E. K., Spellmeyer, D. C., Suto, M. J., and Grootenhuis, P. D. J. (2001) Iterative design of gene-family directed screening libraries Abstracts of Papers, 222nd ACS National Meeting, Chicago, IL, United States, August 26–30, 2001, COMP-053
Grootenhuis, P. D. J., Lamb, M. L., Bradley, E. K., Myers, P. L., Shirley, W. A., Rogers, D., Castellino, A. J., and Miller, J. L. (2003) Process for the informative and iterative design of a gene-family screening library. In: (Deltagen Research Laboratories, L.L.C., USA). Application: WO
Ugi, I., and Steinbrucker, C. (1961) Isonitriles. II. Reaction of isonitriles with carbonyl compounds, amines, and hydrazoic acid Chem. Ber. 94, 734–742
Formerly MDL Drug Data Report, MDDR is produced by Symyx and Prous Science. http://www.symyx.com/products/databases/bioactivity/mddr
Good, A. C., and Lewis, R. A. (1997) New methodology for profiling combinatorial libraries and screening sets: Cleaning up the design process with HARPick J. Med. Chem. 40(24), 3926–3936
Penzotti, J. E., Lamb, M. L., Evensen, E., and Grootenhuis, P. D. J. (2002) A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein J. Med. Chem. 45(9), 1737–1740
Ekins, S., Bravi, G., Binkley, S., Gillespie, J. S., Ring, B. J., Wikel, J. H., and Wrighton, S. A. (1999) Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors J. Pharmacol. Exp. Ther. 290(1), 429–438
Ekins, S., Bravi, G., Wikel, J. H., and Wrighton, S. A. (1999) Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates J. Pharmacol. Exp. Ther. 291(1), 424–433
Sciabola, S., Morao, I., and de Groot, M. J. (2007) Pharmacophoric fingerprint method (TOPP) for 3D-QSAR modeling: Application to CYP2D6 metabolic stability J. Chem. Inf. Model. 47(1), 76–84
Johnson, S. R., Yue, H., Conder, M. L., Shi, H., Doweyko, A. M., Lloyd, J., and Levesque, P. (2007) Estimation of hERG inhibition of drug candidates using multivariate property and pharmacophore SAR Bioorg. Med. Chem. 15(18), 6182–6192
Brady, G. P., and Yang, Z. P. (2008) Pharmacophore fingerprints and application to target class modeling Abstracts of Papers, 235th ACS National Meeting, New Orleans, LA, United States, April 6–10, 2008, COMP-093
Yang, Z., and Brady, G. P. (2008) Applications of target class pharmacophore fingerprint modeling and multi-objective genetic algorithm optimization to large-scale combinatorial library design for corporate compound collection enhancement Abstracts of Papers, 235th ACS National Meeting, New Orleans, LA, United States, April 6–10, 2008, 2008, COMP-094
Bemis, G. W., and Murcko, M. A. (1996) The properties of known drugs. 1. Molecular frameworks J. Med. Chem. 39(15), 2887–2893
Mason, J. S., Cheney, D. L., Menard, P. R., and Morize, I. (1997) New pharmacophore-based methods to search, profile and design diverse and biased compound databases and libraries Book of Abstracts, 214th ACS National Meeting, Las Vegas, NV, September 7–11, COMP-034
Classpharmer is available from Simulations Plus, 42505 10th Street West Lancaster, CA 93534-7059, http://www.simulations-plus.com/
Schnur, D. M., Hermsmeier, M. A., and Tebben, A. J. (2006) Are target-family-privileged substructures truly privileged? J. Med. Chem. 49(6), 2000–2009
Schnur, D., and Hermsmeier, M. A. (2004) Classpharmer and the quest for privileged substructures Abstracts of Papers, 228th ACS National Meeting, Philadelphia, PA, United States, August 22–26, 2004, CINF-080
PipelinePilot is available from Accelrys, Inc., 9685 Scranton Road, San Diego, CA 92121-3752., http://accelrys.com/
ISIS is available from Symyx, http://www.symyx.com/products/software. ISIS was formly available from MDL. ISIS keys and MACCS keys are equivalent
Gianti, E., and Sartori, L. (2008) Identification and selection of “privileged fragments” suitable for primary screening J. Chem. Inf. Model. 48(11), 2129–2139
Horton, D. A., Bourne, G. T., and Smythe, M. L. (2003) The combinatorial synthesis of bicyclic privileged structures or privileged substructures Chem. Rev. 103(3), 893–930
Bleicher, K. H., Green, L. G., Martin, R. E., and Rogers-Evans, M. (2004) Ligand identification for G-protein-coupled receptors: A lead generation perspective Curr. Opin. Chem. Biol. 8(3), 287–296
Merlot, C., Domine, D., Cleva, C., and Church, D. J. (2003) Chemical substructures in drug discovery Drug Discov. Today 8(13), 594–602
Formerly MDL Drug Data Report, MDDR is currently produced by Symyx and Prous Science. The 1999 version was available from MDL which was later purchased by Elsevier and subsequently sold to Symyx
Tripos, 1699 South Hanley Road, St. Louis, MO, 63144
Vaz, R. Private communication
Severinsen, R., Bourne, G. T., Tran, T. T., Ankersen, M., Begtrup, M., and Smythe, M. L. (2008) Library of biphenyl privileged substructures using a safety-catch linker approach J. Comb. Chem. 10(4), 557–566
Bondensgaard, K., Ankersen, M., Thogersen, H., Hansen, B. S., Wulff, B. S., and Bywater, R. P. (2004) Recognition of privileged structures by g-protein coupled receptors J. Med. Chem. 47(4), 888–899
Jimonet, P., and Jaeger, R. (2004) Strategies for designing GPCR-focused libraries and screening sets Curr. Opin. Drug Discov. Devel. 7(3), 325–333
Rodrigues de Sa Alves, F., Barreiro, E. J., and Fraga, C. A. M. (2009) From nature to drug discovery: The indole scaffold as a ‘privileged structure’ Mini Rev. Med. Chem. 9(7), 782–793
Lewis, R. A. (2008) Computer-aided drug design 2005–2007 Chem. Modell. 5, 51–66
Lang, P. T., Aynechi, T., Moustakas, D., Shoichet, B., Kuntz, I. D., Brooijmans, N., and Oshiro, C. M. (2007) Molecular docking and structure-based design Drug Discovery Res. 3–23
Abraham, D. J. (2006) Structure-based drug design – A historical perspective and the future Compr. Med. Chem. II 4, 65–86
Lange, G. (2006) Structure-based drug design – The use of protein structure in drug discovery Compr. Med. Chem. II 4, 597–650
Sun, Y., Ewing, T. J. A., Skillman, A. G., and Kuntz, I. D. (1998) CombiDOCK: Structure-based combinatorial docking and library design J. Comput. Aided Mol. Des. 12(6), 597–604
Shoichet, B. K., Bodian, D. L., and Kuntz, I. D. (1992) Molecular docking using shape descriptors J. Comput. Chem. 13(3), 380–397
Geistlinger, T. R., and Guy, R. K. (2003) Novel selective inhibitors of the interaction of individual nuclear hormone receptors with a mutually shared steroid receptor coactivator 2 J. Am. Chem. Soc. 125(23), 6852–6853
Pitts, W. J., Guo, J., Dhar, T. G. M., Shen, Z., Gu, H. H., Watterson, S. H., Bednarz, M. S., Chen, B. -C., Barrish, J. C., Bassolino, D., Cheney, D., Fleener, C. A., Rouleau, K. A., Hollenbaugh, D. L., and Iwanowicz, E. J. (2002) Rapid synthesis of triazine inhibitors of inosine monophosphate dehydrogenase Bioorg. Med. Chem. Lett. 12(16), 2137–2140
Sprous, D. G., Lowis, D. R., Leonard, J. M., Heritage, T., Burkett, S. N., Baker, D. S., and Clark, R. D. (2004) OptiDock: Virtual HTS of combinatorial libraries by efficient sampling of binding modes in product space J. Comb. Chem. 6(4), 530–539
Shelley, M., Frye, L. L., Sherman, B. W., Rao, S. N., Beard, H., Mozziconacci, J.-C., and Shenkin, P. S. (2007) New approach to lead optimization and core hopping Abstracts of Papers, 234th ACS National Meeting, Boston, MA, United States, August 19–23, 2007, COMP-406
Sherman, B. W., Higgs, C., and Shelley, M. (2007) Screening very large virtual libraries using structure-based docking Abstracts of Papers, 234th ACS National Meeting, Boston, MA, United States, August 19–23, 2007, COMP-165
Shelley, M., Frye, L. L., Murphy, R. B., and Shenkin, P. S. (2006) Focused library design for selective estrogen receptor modulators using CombiGlide Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, United States, Sept. 10–14, 2006, COMP-040
Shenkin, P. S., Frye, L. L., Murphy, R. B., Repasky, M. P., Mainz, D. T., Reboul, M., and Friesner, R. A. (2005) Structure-based design of focused drug-like combinatorial libraries Abstracts of Papers, 230th ACS National Meeting, Washington, DC, United States, Aug. 28–Sept. 1, 2005, COMP-117
Rarey, M., and Lengauer, T. (2000) A recursive algorithm for efficient combinatorial library docking Perspect. Drug Discov. Des. 20, 63–81
Rarey, M., Kramer, B., Lengauer, T., and Klebe, G. (1996) A fast flexible docking method using an incremental construction algorithm J. Mol. Biol. 261(3), 470–489
Rarey, M., Wefing, S., and Lengauer, T. (1996) Placement of medium-sized molecular fragments into active sites of proteins J. Comput. Aided Mol. Des. 10(1), 41–54
Luksch, T., Chan, N. -S., Brass, S., Sotriffer, C. A., Klebe, G., and Diederich, W. E. (2008) Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors ChemMedChem 3(9), 1323–1336
Gerlach, C., Sohn, C., Craan, T., Diederich, W. E., and Klebe, G. (2006) KNOBLE: KNOwledge-based ligand enumeration Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, United States, Sept. 10–14, 2006, COMP-246
Diederich, W. E., Gerlach, C., Blum, A., Boettcher, J., Brass, S., Luksch, T., and Klebe, G. (2006) Design and synthesis of tailor-made compound libraries via a knowledge-based approach: A case study Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, United States, Sept. 10–14, 2006, CINF-083
Cross, S. S. J. (2005) Improved FlexX docking using FlexS-determined base fragment placement J. Chem. Inf. Model. 45(4), 993–1001
Sprous, D., Clark, R., Lowis, D., Leonard, J., and Heritage, T. (2001) Docking combinatorial libraries efficiently using FlexX Abstracts of Papers, 222nd ACS National Meeting, Chicago, IL, United States, August 26–30, 2001, COMP-033
Soltanshahi, F., Liu, Q., and Clark, R. D. (2006) Biasing for favored substituents in kinase library design Abstracts of Papers, 231st ACS National Meeting, Atlanta, GA, United States, March 26–30, 2006, COMP-054
Schrödinger, https://www.schrodinger.com/Documentation.php?mID=6&sID=24&cID=2150&pdID=2150. In: CombiGLIDE documentation, SchrödingerLLC, 120 West 45th Street, 17th Floor, New York, NY 10036
Zhou, J. Z. (2008) Structure-directed combinatorial library design Curr. Opin. Chem. Biol. 12(3), 379–385
Kolb, P., Kipouros, C. B., Huang, D., and Caflisch, A. (2008) Structure-based tailoring of compound libraries for high-throughput screening: Discovery of novel EphB4 kinase inhibitors. Proteins 73(1), 11–18
He, L., Zhang, L., Liu, X., Li, X., Zheng, M., Li, H., Yu, K., Chen, K., Shen, X., Jiang, H., and Liu, H. (2009) Discovering potent inhibitors against the β-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Helicobacter pylori: Structure-based design, synthesis, bioassay, and crystal structure determination J. Med. Chem. 52(8), 2465–2481
Chen, G., Zheng, S., Luo, X., Shen, J., Zhu, W., Liu, H., Gui, C., Zhang, J., Zheng, M., Puah, C. M., Chen, K., and Jiang, H. (2005) Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score J. Comb. Chem. 7(3), 398–406
Hardcastle, I. R., Ahmed, S. U., Atkins, H., Farnie, G., Golding, B. T., Griffin, R. J., Guyenne, S., Hutton, C., Kaellblad, P., Kemp, S. J., Kitching, M. S., Newell, D. R., Norbedo, S., Northen, J. S., Reid, R. J., Saravanan, K., Willems, H. M. G., and Lunec, J. (2006) Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold J. Med. Chem. 49(21), 6209–6221
Stahl, M., Todorov, N. P., James, T., Mauser, H., Boehm, H. -J., and Dean, P. M. (2002) A validation study on the practical use of automated de novo design J. Comput. Aided Mol. Des. 16(7), 459–478
Carr, R., and Jhoti, H. (2002) Structure-based screening of low-affinity compounds Drug Discov. Today 7(9), 522–527
Hajduk, P. J. (2006) Fragment-based drug design: How big is too big? J. Med. Chem. 49(24), 6972–6976
Hajduk, P. J., and Greer, J. (2007) A decade of fragment-based drug design: Strategic advances and lessons learned Nat. Rev. Drug Discov. 6(3), 211–219
Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 46(1–3), 3–26
Congreve, M., Carr, R., Murray, C., and Jhoti, H. (2003) A ‘rule of three’ for fragment-based lead discovery? Drug Discov. Today 8(19), 876–877
Xu, J. (2002) A new approach to finding natural chemical structure classes J. Med. Chem. 45(24), 5311–5320
Siegal, G., Ab, E., and Schultz, J. (2007) Integration of fragment screening and library design Drug Discov. Today 12(23 & 24), 1032–1039
Shuker, S. B., Hajduk, P. J., Meadows, R. P., and Fesik, S. W. (1996) Discovering high-affinity ligands for proteins: SAR by NMR Science 274(5292), 1531–1534
Mayer, M., and Meyer, B. (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy Angew. Chem., Int. Ed. 38(12), 1784–1788
Dalvit, C., Pevarello, P., Tato, M., Veronesi, M., Vulpetti, A., and Sundstrom, M. (2000) Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water J. Biomol. NMR 18(1), 65–68
Vanwetswinkel, S., Heetebrij, R. J., van Duynhoven, J., Hollander, J. G., Filippov, D. V., Hajduk, P. J., and Siegal, G. (2005) TINS, target immobilized NMR screening: An efficient and sensitive method for ligand discovery Chem. Biol. 12(2), 207–216
Phillips, K. S., and Cheng, Q. (2007) Recent advances in surface plasmon resonance based techniques for bioanalysis Anal. Bioanal. Chem. 387(5), 1831–1840
Rich, R. L., and Myszka, D. G. (2000) Advances in surface plasmon resonance biosensor analysis Curr. Opin. Biotechnol. 11(1), 54–61
Neumann, T., Junker, H. D., Schmidt, K., and Sekul, R. (2007) SPR-based fragment screening: Advantages and applications Curr. Top. Med. Chem. 7(16), 1630–1642
Graffinity, http://www.graffinity.com
Carr, R. A. E., Congreve, M., Murray, C. W., and Rees, D. C. (2005) Fragment-based lead discovery: Leads by design Drug Discov. Today 10(14), 987–992
Law, R., Barker, O., Barker, J. J., Hesterkamp, T., Godemann, R., Andersen, O., Fryatt, T., Courtney, S., Hallett, D., and Whittaker, M. (2009) The multiple roles of computational chemistry in fragment-based drug design J. Comput. Aided Mol. Des. 23(8), 459–473
Petros, A. M., Dinges, J., Augeri, D. J., Baumeister, S. A., Betebenner, D. A., Bures, M. G., Elmore, S. W., Hajduk, P. J., Joseph, M. K., Landis, S. K., Nettesheim, D. G., Rosenberg, S. H., Shen, W., Thomas, S., Wang, X., Zanze, I., Zhang, H., and Fesik, S. W. (2006) Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis, J. Med. Chem. 49, 656–663
Dolle, R. E. (1997) Comprehensive survey of chemical libraries yielding enzyme inhibitors, receptor agonists and antagonists, and other biologically active agents: 1992 through 1997 Mol Divers. 3(4), 199–233
Dolle, R. E. (1998) Comprehensive survey of combinatorial libraries with undisclosed biological activity: 1992–1997. Mol. Divers. 4(4), 233–256
Dolle, R. E. (2000) Comprehensive survey of combinatorial library synthesis: 1999 J. Comb. Chem. 2(5), 383–433
Dolle, R. E. (2000) Comprehensive survey of combinatorial libraries with undisclosed biological activity: 1992–1997 Mol. Divers. 4(4), 233–256
Dolle, R. E. (2001) Comprehensive survey of combinatorial library synthesis: 2000 J. Comb. Chem. 3(6), 477–517
Dolle, R. E. (2002) Comprehensive survey of combinatorial library synthesis: 2001 J. Comb. Chem. 4(5), 369–418
Dolle, R. E. (2003) Comprehensive survey of combinatorial library synthesis: 2002 J. Comb. Chem. 5(6), 693–753
Dolle, R. E. (2004) Comprehensive survey of combinatorial library synthesis: 2003 J. Comb. Chem. 6(5), 623–679
Dolle, R. E. (2005) Comprehensive survey of combinatorial library synthesis: 2004 J. Comb. Chem. 7(6), 739–798
Dolle, R. E., Le Bourdonnec, B., Goodman, A. J., Morales, G. A., Salvino, J. M., and Zhang, W. (2007) Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006 J. Comb. Chem. 9(6), 855–902
Dolle, R. E., and Nelson, K. H., Jr. (1999) Comprehensive survey of combinatorial library synthesis: 1998 J. Comb. Chem. 1(4), 235–282
Fitzgerald, S. H., Sabat, M., and Geysen, H. M. (2006) Diversity space and its application to library selection and design J. Chem. Inf. Model. 46(4), 1588–1597
Rush, T. S., III, Grant, J. A., Mosyak, L., and Nicholls, A. (2005) A shape-based 3-D scaffold hopping method and its application to a bacterial protein–protein interaction J. Med. Chem. 48(5), 1489–1495
Fitzgerald, S. H., Sabat, M., and Geysen, H. M. (2007) Survey of the diversity space coverage of reported combinatorial libraries J. Comb. Chem. 9(4), 724–734
Bergmann, R., Linusson, A., and Zamora, I. (2007) SHOP: Scaffold HOPping by GRID-based similarity searches J. Med. Chem. 50(11), 2708–2717
Lead Molecular Design, S.L., Avinguda Cerdanyola 92-94 Local 1.3, 08173 Sant Cugat del Valles, Spain
Molecular Discovery Ltd., 215 Marsh Road,1st Floor, HA55NE, Pinner, Middlesex, UK, http://www.moldiscovery.com
Goodford, P. J. (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules J. Med. Chem. 28(7), 849–857
Fontaine, F., Pastor, M., Zamora, I., and Sanz, F. (2005) Anchor-GRIND: Filling the gap between standard 3D QSAR and the GRid-INdependent descriptors J. Med. Chem. 48(7), 2687–2694
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., and Shenkin, P. S. (2004) Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy J. Med. Chem. 47(7), 1739–1749
Zamora, I. Private communication
Perruccio, F., Mason, J. S., Sciabola, S., and Baroni, M. (2006) FLAP: 4-point pharmacophore fingerprints from GRID Methods Princ. Med. Chem. 27(Molecular Interaction Fields), 83–102
Sayle, R., and Nicholls, A. (2006) Electrostatic evaluation of isosteric analogues J. Comput. Aided Mol. Des. 20(4), 191–208
Jennings, A., and Tennant, M. (2007) Selection of molecules based on shape and electrostatic similarity: Proof of concept of “Electroforms” J. Chem. Inf. Model. 47(5), 1829–1838
Maybridge databases, http://www.maybridge.com/
Good, A. C. (2007) Novel DOCK clique driven 3D similarity database search tools for molecule shape matching and beyond: Adding flexibility to the search for ligand kin J. Mol. Graph. Model. 26(3), 656–666
Cramer, R. D., Cruz, P., Stahl, G., Curtiss, W. C., Campbell, B., Masek, B. B., and Soltanshahi, F. (2008) Virtual screening for R-Groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA J. Chem. Inf. Model. 48(11), 2180–2195
Truchon, J. -F., and Bayly, C. I. (2006) Is there a single ‘best pool’ of commercial reagents to use in combinatorial library design to conform to a desired product-property profile? Aust. J. Chem. 59(12), 879–882
Truchon, J. -F., and Bayly, C. I. (2006) GLARE: A new approach for filtering large reagent lists in combinatorial library design using product properties J. Chem. Inf. Model. 46(4), 1536–1548
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Schnur, D.M., Beno, B.R., Tebben, A.J., Cavallaro, C. (2010). Methods for Combinatorial and Parallel Library Design. In: Bajorath, J. (eds) Chemoinformatics and Computational Chemical Biology. Methods in Molecular Biology, vol 672. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-839-3_16
Download citation
DOI: https://doi.org/10.1007/978-1-60761-839-3_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-838-6
Online ISBN: 978-1-60761-839-3
eBook Packages: Springer Protocols